KeyCorp Upgrades Rapid Micro Biosystems (NASDAQ:RPID) to Strong-Buy

Rapid Micro Biosystems (NASDAQ:RPID) was upgraded by research analysts at KeyCorp to a “strong-buy” rating in a report released on Tuesday,Zacks.com reports.

Rapid Micro Biosystems Price Performance

Shares of NASDAQ RPID opened at $3.26 on Tuesday. The stock has a market capitalization of $140.28 million, a P/E ratio of -2.91 and a beta of 1.26. Rapid Micro Biosystems has a one year low of $0.58 and a one year high of $3.30. The firm’s 50 day simple moving average is $1.40 and its two-hundred day simple moving average is $1.09.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.